Peter Feinberg
Director/Board Member at IMMUNEERING CORPORATION
Net worth: 2 M $ as of 2024-04-29
Profile
Peter Feinberg is the founder of BridgeBio Pharma, Inc. (founded in 2014), Boxcar PMJ LLC (founded in 2019), and Sporos Bioventures, Inc. (founded in 2020) where he holds the title of Director.
Mr. Feinberg is also the founder of North Coast Partners LLP.
Currently, Mr. Feinberg holds the position of Independent Director at Immuneering Corp.
(since 2021), Notable Labs Ltd.
(since 2023), and Partner at Boxcar Partners (since 2019).
In the past, Mr. Feinberg worked at Oppenheimer & Co., Inc. from 1982 to 2015, where he held the title of MD & Head-Institutional Equities Trading in 2015.
Mr. Feinberg completed his undergraduate degree at Whittier College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-17 | 1,096,064 ( 3.70% ) | 2 M $ | 2024-04-29 | |
0.45% | 2024-05-07 | 40,247 ( 0.45% ) | 38 637 $ | 2024-04-29 |
Peter Feinberg active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNEERING CORPORATION | Director/Board Member | 2020-12-31 |
Boxcar PMJ LLC
 Boxcar PMJ LLC Boxcar PMJ LLC is an Independent Venture Capital firm founded in 2019 by Peter Feinberg. The firm is headquartered in the US. | Founder | 2019-05-31 |
Sporos Bioventures, Inc.
 Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino. | Founder | 2020-03-31 |
| Boxcar Partners | Corporate Officer/Principal | 2019-05-31 |
Former positions of Peter Feinberg
| Companies | Position | End |
|---|---|---|
Oppenheimer & Co., Inc.
 Oppenheimer & Co., Inc. Investment ManagersFinance Oppenheimer & Co., Inc. provides security brokerage services. It also offers investment banking and advice to high net worth investors, individuals, businesses and institutions. The company is headquartered in New York, NY. | Corporate Officer/Principal | 2015-01-30 |
| North Coast Partners LLP | Founder | - |
| BRIDGEBIO PHARMA, INC. | Founder | - |
Training of Peter Feinberg
| Whittier College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| IMMUNEERING CORPORATION | Health Technology |
| BRIDGEBIO PHARMA, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Oppenheimer & Co., Inc.
Oppenheimer & Co., Inc. Investment ManagersFinance Oppenheimer & Co., Inc. provides security brokerage services. It also offers investment banking and advice to high net worth investors, individuals, businesses and institutions. The company is headquartered in New York, NY. | Finance |
Boxcar PMJ LLC
Boxcar PMJ LLC Boxcar PMJ LLC is an Independent Venture Capital firm founded in 2019 by Peter Feinberg. The firm is headquartered in the US. | |
Sporos Bioventures, Inc.
Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino. | Health Services |
| Boxcar Partners | |
| North Coast Partners LLP |
- Stock Market
- Insiders
- Peter Feinberg
